Related Experiment Video
Updated: Jul 19, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Helicobacter pylori: microbiology and interactions with gastrointestinal microflora
K Dzierzanowska-Fangrat1, D Dzierzanowska
1Department of Clinical Microbiology & Immunology, Children's Memorial Health Institute, Aleja Dzieci Polskich 20, 04-730 Warsaw, Poland. fangrat@supermedia.pl
Abstract:
Helicobacter pylori causes substantial morbidity and mortality, and the course of infection results from complex interactions between host, environmental and bacterial factors. It is generally accepted that H. pylori eradication is the best method of treatment for peptic ulcer disease and prevention of its complications. However, the antimicrobial agents used in eradication regimens cause various alterations in gastrointestinal microflora, which can lead to side effects affecting the patient's compliance. Moreover, antimicrobial therapy is responsible for increasing resistance not only in H. pylori but also in colonising microflora, and, therefore, alternative approaches to the treatment and prevention of H. pylori infection have been investigated.
Related Concept Videos
Microbiota of the Stomach and Small Intestine
Gastritis II: Pathophysiology
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
